Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Virpax Pharmaceuticals ( (VRPX) ) has provided an update.
On April 2, 2025, Virpax Pharmaceuticals received a delisting notice from the Nasdaq Hearings Panel due to non-compliance with the minimum stockholders’ equity requirement. The company’s stock trading will be suspended on April 4, 2025, with delisting finalized after the appeal period. Additionally, on the same day, several board members and the CFO resigned, with no disagreements cited as the cause.
More about Virpax Pharmaceuticals
YTD Price Performance: -87.16%
Average Trading Volume: 364,334
Technical Sentiment Signal: Strong Buy
Current Market Cap: $1.59M
Learn more about VRPX stock on TipRanks’ Stock Analysis page.